On August 22, 2023, Immix Biopharma, Inc. closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.374 USD | +7.90% | +6.25% | -65.61% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.61% | 58.09M | |
-1.26% | 89.46B | |
+2.76% | 40.74B | |
-8.90% | 33.03B | |
+55.32% | 24.68B | |
-16.41% | 15.12B | |
-8.97% | 12.81B | |
-12.11% | 11.79B | |
-43.61% | 11.64B | |
+7.79% | 8.9B |
- Stock Market
- Equities
- IMMX Stock
- News Immix Biopharma, Inc.
- Immix Biopharma, Inc. announced that it has received $9.999998 million in funding